Barclays’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.48M Buy
1,012,956
+506,168
+100% +$2.99M ﹤0.01% 1884
2025
Q4
$2.71M Buy
506,788
+274,424
+118% +$2.18M ﹤0.01% 2708
2025
Q3
$2.24M Buy
232,364
+56,416
+32% +$520K ﹤0.01% 2810
2025
Q2
$1.29M Buy
175,948
+91,407
+108% +$613K ﹤0.01% 3160
2025
Q1
$396K Sell
84,541
-23,416
-22% -$117K ﹤0.01% 3665
2024
Q4
$489K Buy
107,957
+35,627
+49% +$190K ﹤0.01% 3842
2024
Q3
$201K Buy
72,330
+58,897
+438% +$157K ﹤0.01% 4278
2024
Q2
$41.1K Buy
+13,433
New +$51.8K ﹤0.01% 4287

Other funds holding ASPI

Barclays's ASPI Position: Q1 2026 in Review

Barclays increased its ASP Isotopes (ASPI) stake by 100% in Q1 2026, buying an estimated $2.99M and bringing the position to 1,012,956 shares worth $4.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1884.

Barclays first reported a position in ASPI in Q2 2024 and has held it in 8 quarters since. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

  • Barclays held 1,012,956 shares of ASP Isotopes worth $4.48M as of Q1 2026.
  • Barclays bought 506,168 ASP Isotopes shares in Q1 2026, an estimated $2.99M.
  • ASP Isotopes made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1884 holding.
  • Barclays first reported a position in ASP Isotopes in Q2 2024 and has held it in 8 quarters since.
  • 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.